Kappa Opioid Receptor Imaging in Depression (KOR Depression)

Trial Profile

Kappa Opioid Receptor Imaging in Depression (KOR Depression)

Phase of Trial: Phase IV

Latest Information Update: 19 Aug 2016

At a glance

  • Drugs LY 2795050 (Primary)
  • Indications Major depressive disorder
  • Focus Pharmacokinetics
  • Acronyms KOR Depression
  • Most Recent Events

    • 29 Apr 2016 Status changed from completed to discontinued.
    • 02 Mar 2016 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
    • 26 Jun 2015 Planned End Date changed from 1 Jul 2019 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top